Lenient versus Strict Rate Control in Patients with Atrial Fibrillation
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Rate control is often the therapy of choice for atrial fibrillation. Guidelines recommend strict rate control, but this is not based on clinical evidence. We hypothesized that lenient rate control is not inferior to strict rate control for preventing cardiovascular morbidity and mortality in patients with permanent atrial fibrillation. METHODS: We randomly assigned 614 patients with permanent atrial fibrillation to undergo a lenient rate-control strategy (resting heart rate <110 beats per minute) or a strict rate-control strategy (resting heart rate <80 beats per minute and heart rate during moderate exercise <110 beats per minute). The primary outcome was a composite of death from cardiovascular causes, hospitalization for heart failure, and stroke, systemic embolism, bleeding, and life-threatening arrhythmic events. The duration of follow-up was at least 2 years, with a maximum of 3 years. RESULTS: The estimated cumulative incidence of the primary outcome at 3 years was 12.9% in the lenient-control group and 14.9% in the strict-control group, with an absolute difference with respect to the lenient-control group of -2.0 percentage points (90% confidence interval, -7.6 to 3.5; P<0.001 for the prespecified noninferiority margin). The frequencies of the components of the primary outcome were similar in the two groups. More patients in the lenient-control group met the heart-rate target or targets (304 [97.7%], vs. 203 [67.0%] in the strict-control group; P<0.001) with fewer total visits (75 [median, 0], vs. 684 [median, 2]; P<0.001). The frequencies of symptoms and adverse events were similar in the two groups. CONCLUSIONS: In patients with permanent atrial fibrillation, lenient rate control is as effective as strict rate control and is easier to achieve. (ClinicalTrials.gov number, NCT00392613.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There was no difference in a composite of clinical events (14.9% in the strict rate control group, 12.9% in the lenient group), 560 NYHA class, or hospitalizations.560, 561”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [560]
Citations
Cites
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Self-citationVan Gelder, I. C., Hagens, V. E., Bosker, H. A., Kingma, J. H., Kamp, O., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,359
Self-citationEffect of Dronedarone on Cardiovascular Events in Atrial Fibrillation
Hohnloser, S. H., Crijns, H. J. G. M., van Eickels, M., Gaudin, C., Page, R. L., Torp-Pedersen, C., & Connolly, S. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803778 · Cited by 1,129
Self-citationAtrial Fibrillation and Heart Failure: Treatment Considerations for a Dual Epidemic
Anter, E., Jessup, M., & Callans, D. J. (2009) · Circulation · doi:10.1161/circulationaha.108.821306 · Cited by 678
Lechat, P., Hulot, J.-S., Escolano, S., Mallet, A., Leizorovicz, A., Werhlen-Grandjean, M., Pochmalicki, G., & Dargie, H. (2001) · Circulation · doi:10.1161/01.cir.103.10.1428 · Cited by 525
Nerheim, P., Birger-Botkin, S., Piracha, L., & Olshansky, B. (2004) · Circulation · doi:10.1161/01.cir.0000135472.28234.cc · Cited by 378
Van Gelder, I. C., Crijns, H. J. G. M., Blanksma, P. K., Landsman, M. L. J., Posma, J. L., Van Den Berg, M. P., Meijler, F. L., & Lie, K. I. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90352-d · Cited by 269
Self-citationConnolly, S. J., Crijns, H. J. G. M., Torp-Pedersen, C., van Eickels, M., Gaudin, C., Page, R. L., & Hohnloser, S. H. (2009) · Circulation · doi:10.1161/circulationaha.109.875252 · Cited by 261
Self-citation
Cited by
Items 101–200 of 999
JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies
Kitaoka, H., Tsutsui, H., Kubo, T., Ide, T., Chikamori, T., Fukuda, K., Fujino, N., Higo, T., Isobe, M., Kamiya, C., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-20-0910 · Cited by 134
Linz, D., Andrade, J. G., Arbelo, E., Boriani, G., BREITHARDT, G. E., Camm, A. J., Caso, V., Nielsen, J. C., Melis, M. D., Potter, T. J. R. D., et al. (2024) · EP Europace · doi:10.1093/europace/euae070 · Cited by 129
“44,45 Medical rate control therapy should be part of active rhythm management in patients with AF, considering the rate-controlling effects of several antiarrhythmic drugs, including amiodar-one, dronedarone, propafenone, and sotalol.”
BackgroundUlimoen, S. R., Enger, S., Carlson, J., Platonov, P. G., Pripp, A. H., Abdelnoor, M., Arnesen, H., Gjesdal, K., & Tveit, A. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.09.020 · Cited by 113
Andrade, J. G., Macle, L., Nattel, S., Verma, A., & Cairns, J. A. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.06.002 · Cited by 115
Wann, L. S., Curtis, A. B., January, C. T., Ellenbogen, K. A., Lowe, J. E., Estes, N. A. M., Page, R. L., Ezekowitz, M. D., Slotwiner, D. J., Jackman, W. M., et al. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.11.047 · Cited by 114
The Importance of Whether Atrial Fibrillation or Heart Failure Develops First
Smit, M. D., Moes, M. L., Maass, A. H., Achekar, I. D., Van Geel, P. P., Hillege, H. L., van Veldhuisen, D. J., & Van Gelder, I. C. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs097 · Cited by 100
“Heart failure hospitalization was defined as heart failure necessitating hospitalization and the start of or increase in dose of diuretics.(13,14) Persistent AF was defined as an AF episode lasting longer than 7 days or requiring termination by cardioversion.”
MethodSelf-citationBurrage, M. K., Hundertmark, M., Valkovič, L., Watson, W. D., Rayner, J. J., Sabharwal, N. K., Ferreira, V. M., Neubauer, S., Miller, J. J. J. J., Rider, O. J., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.054858 · Cited by 104
A real-time approach for heart rate monitoring using a Hilbert transform in seismocardiograms
Tadi, M. J., Lehtonen, E., Hurnanen, T., Koskinen, J., Eriksson, J., Pänkäälä, M., Teräs, M., & Koivisto, T. (2016) · Physiological Measurement · doi:10.1088/0967-3334/37/11/1885 · Cited by 111
Quality indicators for the care and outcomes of adults with atrial fibrillation
Arbelo, E., (Chair), Aktaa, S., Bollmann, A., D’Avila, A., Drossart, I., Dwight, J., Hills, M. T., Hindricks, G., Kusumoto, F. M., et al. (2021) · EP Europace · doi:10.1093/europace/euaa253 · Cited by 97
Cheung, C. C., Nattel, S., Macle, L., & Andrade, J. G. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.06.011 · Cited by 113
Kelly, J. P., DeVore, A. D., Wu, J., Hammill, B. G., Sharma, A., Cooper, L. B., Felker, G. M., Piccini, J. P., Allen, L. A., Heidenreich, P. A., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011560 · Cited by 97
for the ATRIUM investigators, Meinertz, T., Kirch, W., Rosin, L., Pittrow, D., Willich, S. N., & Kirchhof, P. (2011) · Clinical Research in Cardiology · doi:10.1007/s00392-011-0320-5 · Cited by 91
Boriani, G., Fauchier, L., Aguinaga, L., Beattie, J. M., Lundqvist, C. B., Cohen, A. A., Dan, G., Genovesi, S., Israel, C. W., Joung, B., et al. (2018) · EP Europace · doi:10.1093/europace/euy110 · Cited by 102
Self-citationUlimoen, S. R., Enger, S., Pripp, A. H., Abdelnoor, M., Arnesen, H., Gjesdal, K., & Tveit, A. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht429 · Cited by 87
“In the RACE II study, most patients received beta-blockers; only 5–6% received calcium channel blockers as the only rate-reducing drug.(45) Whether more frequent use of calcium channel blockers in the RACE II study would have affected the outcomes with regard to symptoms and quality of life remains unknown.”
Management of Arrhythmias in Heart Failure
Masarone, D., Limongelli, G., Rubino, M., Valente, F., Vastarella, R., Ammendola, E., Gravino, R., Verrengia, M., Salerno, G., & Pacileo, G. (2017) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd4010003 · Cited by 102
“The target for heart rate in the AF Follow-up Investigation of Rhythm Management (AFFIRM) trial was defined as less than 80 beats per minute at rest, and 110 beats per minute during a 6 min walk test; however, the Rate Control Efficacy (RACE-2) trial randomized patients to conventional strict control (<80 beats per mi…”
MethodDobre, D., BORER, J. S., Fox, K. M., Swedberg, K. B., Adams, K. F., Cleland, J. G. F., Solal, A. C., Gheorghiade, M., Gueyffier, F., O’Connor, C. M., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft129 · Cited by 90
“The optimal ventricular rate in patients with chronic HF-rEF and AF is uncertain, but appears higher than for sinus rhythm.(28)”
BackgroundFrendl, G., Sodickson, A., Chung, M. K., Waldo, A. L., Gersh, B. J., Tisdale, J. E., Calkins, H. G., Aranki, S. F., Kaneko, T., Cassivi, S. D., et al. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.06.037 · Cited by 84
Digoxin and Risk of Death in Adults With Atrial Fibrillation: The ATRIA-CVRN Study
Freeman, J. V., Reynolds, K., Fang, M., Udaltsova, N., Steimle, A., Pomernacki, N. K., Borowsky, L. H., Harrison, T. N., Singer, D. E., & Go, A. S. (2015) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.114.002292 · Cited by 80
Heart Rate and Heart Failure With Preserved Ejection Fraction
Meyer, M., & LeWinter, M. M. (2019) · Circulation Heart Failure · doi:10.1161/circheartfailure.119.006213 · Cited by 81
Sliwa, K., Carrington, M. J., Klug, E., Opie, L., Lee, G., Ball, J., & Stewart, S. (2010) · Heart · doi:10.1136/hrt.2010.206938 · Cited by 80
“Likewise, lenient ventricular rate control is as good as strict control and the key is reasonable control by b-blockade.(25) Digoxin treatment remains problematic given the need for regular and potentially expensive therapeutic monitoring.”
BackgroundPostoperative atrial fibrillation (POAF) after cardiac surgery: clinical practice review
Suero, O. R., Ali, A. K., Barron, L. M., Segar, M. W., Moon, M. R., & Chatterjee, S. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-23-1626 · Cited by 101
“…difference between lenient rate control (resting heart rate 110 bpm) and strict rate control (resting heart rate 80 bpm) with respect to death from cardiovascular causes, hospitalization for heart failure, stroke, systemic embolism, bleeding, and life-threatening arrhythmic events (77).”
Comparison of Atrial Fibrillation in the Young versus That in the Elderly: A Review
Sankaranarayanan, R., Kirkwood, G., Dibb, K., & Garratt, C. J. (2013) · Cardiology Research and Practice · doi:10.1155/2013/976976 · Cited by 78
“Abbreviations AF: Atrial �brillation APD: Action potential duration ERP: Effective refractory period.”
BackgroundThe ups and downs of heart rate
Magder, S. A. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318232e50c · Cited by 81
Verdonschot, J. A. J., Hazebroek, M. R., Ware, J. S., Prasad, S. K., & Heymans, S. R. B. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012514 · Cited by 80
“In general, rhythm control does not provide a benefit in all-causemortality or worseningHF as compared with rate control, with similar findings in strict versus lenient rate control.(35) In AF-mediated DCM, rhythm control is superior to rate control in improving LVEF, pro-brain natriuretic peptide levels, and quality…”
ResultHanon, O., Assayag, P., Belmin, J., Collet, J., Émeriau, J. P., Fauchier, L., Forette, F., Friocourt, P., Gentric, A., Leclercq, C., et al. (2013) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2013.04.001 · Cited by 87
Practical Management of Postoperative Atrial Fibrillation after Noncardiac Surgery
Danelich, I. M., Lose, J. M., Wright, S. S., Asirvatham, S. J., Ballinger, B. A., Larson, D. W., & Lovely, J. K. (2014) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2014.02.038 · Cited by 81
Varma, N., Cygankiewicz, I., Turakhia, M. P., Heidbuchel, H., Hu, Y.-F., Chen, L. Y., Couderc, J.-P., Cronin, E. M., Estep, J. D., Grieten, L., et al. (2021) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.120.009204 · Cited by 74
Randomized Trials Versus Common Sense and Clinical Observation
Fanaroff, A. C., Califf, R. M., Harrington, R. A., Granger, C. B., McMurray, J. J. V., Patel, M. R., Bhatt, D. L., Windecker, S., Hernandez, A. F., Gibson, C. M., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.069 · Cited by 80
“Higher heart rates in patients with atrial fibrillation are associated with worse outcomes (33), but tighter heart rate control did not translate into improved outcomes in an RCT (34).”
BackgroundAsymptomatic persistent atrial fibrillation and outcome: Results of the RACE study
Rienstra, M., Vermond, R. A., Crijns, H. J. G. M., Tijssen, J. G. P., & Gelder, I. C. V. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.03.016 · Cited by 82
Self-citationNew-Onset Atrial Fibrillation After Cardiac Surgery: Pathophysiology, Prophylaxis, and Treatment
Ломиворотов, В. В., Efremov, S. M., Pokushalov, E. A., & Karaskov, A. M. (2015) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2015.08.003 · Cited by 78
Digoxin in patients with permanent atrial fibrillation: Data from the RACE II study
Mulder, B. A., van Veldhuisen, D. J., Crijns, H. J. G. M., Tijssen, J. G. P., Hillege, H. L., Alings, M., Rienstra, M., van den Berg, M. P., & Gelder, I. C. V. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.06.007 · Cited by 80
Self-citationManagement of Atrial Fibrillation in Critically Ill Patients
Arrigo, M., Béttex, D., & Rudiger, A. (2014) · Critical Care Research and Practice · doi:10.1155/2014/840615 · Cited by 84
Mulder, B. A., van Veldhuisen, D. J., Crijns, H. J. G. M., Böhm, M., Solal, A. C., Babalis, D. S., Roughton, M., Flather, M. D., Coats, A. J. S., & Gelder, I. C. V. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs100 · Cited by 70
Self-citationEnfermedad cardiovascular en el anciano
Jackson, C. F., & WENGER, N. K. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2011.05.001 · Cited by 95
Bui, A. L., Grau‐Sepulveda, M. V., Hernandez, A. F., Peterson, E. D., Yancy, C. W., Bhatt, D. L., & Fonarow, G. C. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.01.007 · Cited by 69
An update on atrial fibrillation in 2014: From pathophysiology to treatment
Ferrari, R., Bertini, M., Blomström‐Lundqvist, C., Dobrev, D., Kirchhof, P. F., Pappone, C., Ravens, U., Tamargo, J. L., Tavazzi, L., & Vicedomini, G. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.10.089 · Cited by 84
“A recent trial in 614 patients with permanent AF demonstrated that more lenient rate control (to a target of b110 bpm) was as effective as stricter control (to b80 bpm) for both outcomes and symptoms [38].”
BackgroundSmart, N. A., King, N., Lambert, J. D., Pearson, M. J., Campbell, J. L., Risom, S. S., & Taylor, R. S. (2018) · Open Heart · doi:10.1136/openhrt-2018-000880 · Cited by 67
“21).(42) Our analysis showed left ventricular ejection fraction was significantly increased by exercise-based CR versus control participants.”
MethodNattel, S., Sager, P. T., Hüser, J., Heijman, J., & Dobrev, D. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab093 · Cited by 67
“min during moderate exercise) compared to lenient (<110 beats/min at rest) rate-control strategy.(16) It must be noted that the treating physicians”
BackgroundHeart rate is associated with progression of atrial fibrillation, independent of rhythm
Holmqvist, F., Kim, S., Steinberg, B. A., Reiffel, J. A., Mahaffey, K. W., Gersh, B. J., Fonarow, G. C., Naccarelli, G. V., Chang, P., Freeman, J. V., et al. (2015) · Heart · doi:10.1136/heartjnl-2014-307043 · Cited by 73
Steinberg, B. A., Kim, S., Thomas, L. E., Fonarow, G. C., Gersh, B. J., Holmqvist, F., Hylek, E. M., Kowey, P. R., Mahaffey, K. W., Naccarelli, G. V., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002031 · Cited by 65
“However, target heart rates are not well established and clinical trials to date have failed to demonstrate a benefit to strict heart rate control (<80 beats per minute [bpm]) relative to a more-lenient rate control strategy (ie, <110 bpm).(6)”
BackgroundResultThomas, M., Wu, L., & Win, K. (2014) · Journal of Biomedical Research · doi:10.7555/jbr.28.20130191 · Cited by 83
Chen, A. Y., Sokol, S. S., Kress, J. P., & Lat, I. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015574726 · Cited by 63
“Extrapolation of management strategies in ambulatory patients may not demonstrate the same benefit in critically ill patients with new-onset AF.16,17 Additionally, treatment decisions for arrhythmia management and anticoagulation for stroke prevention made in the ambulatory population may be contraindicated in critica…”
BackgroundInfluentialCleland, J. G. F., Coletta, A. P., Buga, L., Ahmed, D., & Clark, A. L. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq083 · Cited by 62
Rationale and current perspective for early rhythm control therapy in atrial fibrillation
Gelder, I. C. V., Haegeli, L. M., Brandes, A., Heidbüchel, H., Aliot, E., Kautzner, J., Szumowski, Ł. J., Mont, L., Morgan, J. M., Willems, S., et al. (2011) · EP Europace · doi:10.1093/europace/eur192 · Cited by 67
“Figure 1 Yearly cardiovascular morbidity and mortality rate in the Rate Control Versus Electrical Cardioversion (RACE) I study (published in 2002) and the RAte Control Efficacy in permanent atrial fibrillation (RACE) II study (published in 2010).(7,20) Early rhythm control for atrial fibrillation 1519”
BackgroundHopper, I., Samuel, R., Hayward, C., Tonkin, A., & Krum, H. (2014) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2014.04.013 · Cited by 67
Saglietto, A., Scarsoglio, S., Ridolfi, L., Gaïta, F., & Anselmino, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-40445-5 · Cited by 66
Groenveld, H. F., Tijssen, J. G. P., Crijns, H. J. G. M., van den Berg, M. P., Hillege, H. L., Alings, M., van Veldhuisen, D. J., & Gelder, I. C. V. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.038 · Cited by 65
“However, not all patients achieved the heart rate target, especially not in the strict group (7).”
BackgroundMethodInfluentialSelf-citationHeart Rate and Heart Failure - Not a Simple Relationship -
Heusch, G. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0925 · Cited by 65
Camm, A. J., Savelieva, I., Ho, S. Y., Lindsay, B. D., Nattel, S., & Shinagawa, K. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4377-0285-9.00044-2 · Cited by 62
Nielsen, P. B., Larsen, T. B., Gorst‐Rasmussen, A., Skjøth, F., & Lip, G. Y. H. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002597 · Cited by 65
Sethi, N. J., Nielsen, E. E., Safi, S., Feinberg, J. B., Gluud, C. N., & Jakobsen, J. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193924 · Cited by 66
2026 ESC Guidelines for the management of heart failure
Køber, L., Adamo, M., Ruwald, A., Tomasoni, D., Anderson, L., Andersson, C., Brugts, J. J., Chioncel, O. D., Donal, E., Ferdinandy, P., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag100 · Cited by 159
Simpson, J., Castagno, D., Doughty, R. N., Poppe, K., Earle, N. J., Squire, I. B., Richards, M., Andersson, B., Ezekowitz, J. A., Komajda, M., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.346 · Cited by 62
Atrial Fibrillation and Race – A Contemporary Review
Amponsah, M., Benjamin, E. J., & Magnani, J. W. (2013) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-013-0327-8 · Cited by 56
“Strict rate control in AF (heart rates <80 beats per minute) is not superior to more lenient approaches to rate control (heart rate less than 110) [86].”
Jung, S., Sun, W., Griffiths, L. G., & Kittleson, M. D. (2015) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.13800 · Cited by 55
Boriani, G., Gasparini, M., Landolina, M., Lunati, M., Proclemer, A., LONARDI, G., Iacopino, S., Rahue, W., Biffi, M., DiStefano, P., et al. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr046 · Cited by 57
Hohendanner, F., Heinzel, F. R., Blaschke, F., Pieske, B. M., Haverkamp, W., Boldt, H., & Parwani, A. S. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9657-9 · Cited by 60
“For rate control, appropriately dosed beta blockers [36], Ca antagonists or digoxin are drugs commonly used in clinical practice.”
BackgroundRate Control in Atrial Fibrillation: Targets, Methods, Resynchronization Considerations
Heist, E. K., MANSOUR, M. C., & Ruskin, J. N. (2011) · Circulation · doi:10.1161/circulationaha.111.019919 · Cited by 61
Cardiovascular Disease in the Elderly
Jackson, C. F., & WENGER, N. K. (2011) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2011.05.003 · Cited by 78
Should β-Blockers Be Used in Patients With Heart Failure and Atrial Fibrillation?
Mareev, Y. V., & Cleland, J. G. F. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.08.017 · Cited by 63
Lee, K.-J., Kim, B. J., Han, M.-K., Kim, J.-T., Choi, K.-H., Shin, D.-I., Yeo, M.-J., Cha, J.-K., Kim, D.-H., Nah, H.-W., et al. (2020) · Stroke · doi:10.1161/strokeaha.119.026847 · Cited by 52
Nattel, S. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2010.11.004 · Cited by 56
Smit, M. D., Crijns, H. J. G. M., Tijssen, J. G. P., Hillege, H. L., Alings, M., Tuininga, Y. S., Groenveld, H. F., van den Berg, M. P., van Veldhuisen, D. J., & Gelder, I. C. V. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.04.030 · Cited by 60
“that lenient rate control is not inferior to strict rate control in preventing cardiovascular events in patients with permanent AF (6).”
BackgroundMethodInfluentialSelf-citationThe current approach of atrial fibrillation management
Amin, A., Houmsse, A., Ishola, A., Tyler, J. D., & Houmsse, M. (2016) · Avicenna Journal of Medicine · doi:10.4103/2231-0770.173580 · Cited by 71
“[27] Newer evaluations of rate control compared lenient rate control (resting heart rates as high as 110 beats/min) to strict rate control similar to the AFFIRM study and showed a 2% absolute reduction in the death from cardiovascular cause, hospitalization for CHF, life‐threatening arrhythmogenic events, stroke or sy…”
Varma, N., Cygankiewicz, I., Turakhia, M. P., Heidbüchel, H., Hu, Y., Chen, L. Y., Couderc, J., Cronin, E. M., Estep, J. D., Grieten, L., et al. (2021) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12795 · Cited by 54
Sarkar, S., Koehler, J. L., Crossley, G. H., Tang, W. H. W., Abraham, W. T., Warman, E. N., & Whellan, D. J. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.06.020 · Cited by 50
Antiarrhythmic therapy in atrial fibrillation
Ravens, U. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.06.004 · Cited by 48
Metzner, A., Suling, A. I., Brandes, A., BREITHARDT, G. E., Camm, A. J., Crijns, H. J. G. M., Eckardt, L., Elvan, A., Goette, A., Haegeli, L., et al. (2021) · EP Europace · doi:10.1093/europace/euab200 · Cited by 51
“Digoxin was used in a very small number of patients, and almost entirely as second-line therapy on top of beta-blockers, following current recommendations and trial results.(18) Whether this remains best practice in patients with AF and heart failure remains to be tested in light of the recently published RATE-AF tria…”
MethodSelf-citationJCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E. T., Sato, K., TERAMOTO, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.02.014 · Cited by 67
Machino‐Ohtsuka, T., Seo, Y., Ishizu, T., Yamamoto, M., Hamada‐Harimura, Y., Machino, T., Yamasaki, H., Sekiguchi, Y., Nogami, A., Aonuma, K., et al. (2019) · Journal of Cardiology · doi:10.1016/j.jjcc.2019.02.014 · Cited by 49
Lévy, S., Steinbeck, G., Santini, L., Näbauer, M., Penela, D., Kantharia, B. K., Saksena, S. V., & Cappato, R. (2022) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-022-01195-z · Cited by 52
“compared “lenient” (<110 bpm at rest) and strict (<80 bpm) rate control and found that lenient rate control was as effective as strict rate control and was easier to achieve [17].”
BackgroundShariff, N., Desai, R. V., Patel, K., Ahmed, M. I., Fonarow, G. C., Rich, M. W., Aban, I., Banach, M., Love, T. E., White, M., et al. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.04.021 · Cited by 46
“However, strict rate control has not been shown to be associated with better outcomes.(30) The prevalence of use of beta-blockers was low, and only 14 patients had ablationbased rhythm-control therapy, which may limit generalizability to contemporary younger patients with severe symptoms associated with atrial fibrill…”
Kotecha, D., Calvert, M., Deeks, J. J., GRIFFITH, M. J., Kirchhof, P. F., Lip, G. Y. H., Mehta, S. P., Slinn, G., Stanbury, M., Steeds, R. P., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015099 · Cited by 48
Heart rate as a prognostic marker and therapeutic target in acute and chronic heart failure
Oliva, F. G., Sormani, P., Contri, R., Campana, C., Carubelli, V., Cirò, A., Morandi, F., Tano, G. D., Mortara, A., Senni, M., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.09.191 · Cited by 52
Kloosterman, M., Crijns, H. J. G. M., Mulder, B. A., Groenveld, H. F., van Veldhuisen, D. J., Rienstra, M., & Gelder, I. C. V. (2019) · EP Europace · doi:10.1093/europace/euz300 · Cited by 53
Self-citationCatheter ablation for atrial fibrillation in HFpEF patients—A propensity‐score‐matched analysis
Rattka, M., Kühberger, A., Pott, A., Stephan, T., Weinmann, K., Baumhardt, M., Aktolga, D., Teumer, Y., Bothner, C., Scharnbeck, D., et al. (2021) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15200 · Cited by 50
“In the medical treatment group a target resting heart rate of at least less than 110 bpm for rate control was pursued, however, heart rates of 60–80 bpm were considered as the optimal target in heart failure patients whenever achievable.(13) Baseline and follow‐up blood samples were drawn at hospital admission or at p…”
BackgroundAtrial fibrillation: mechanism and clinical management
Hu, Z., Ding, L., & Yao, Y. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002906 · Cited by 64
“[69] Therefore, the initial ventricular rate control target for AF patients can be set at a resting heart rate 110 beats/min.”
Chinese guidelines for the diagnosis and management of atrial fibrillation
Ma, C., Wu, S., Liu, S., & Han, Y. (2024) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14920 · Cited by 50
Incidence of atrial fibrillation in pregnancy and clinical significance: A meta-analysis
Chokesuwattanaskul, R., Thongprayoon, C., Bathini, T. J., O’Corragain, O. A., Sharma, K., Prechawat, S., Ungprasert, P., Watthanasuntorn, K., Pachariyanon, P., & Cheungpasitporn, W. (2019) · Advances in Medical Sciences · doi:10.1016/j.advms.2019.07.003 · Cited by 51
Atrial Fibrillation and Heart Failure
Ariyaratnam, J., Lau, D. H., Sanders, P., & Kalman, J. M. (2021) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2020.11.004 · Cited by 56
JCS / JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
Ono, K., Iwasaki, Y., Akao, M., Ikeda, T., Ishii, K., Inden, Y., Kusano, K., Kobayashi, Y., Koretsune, Y., Sasano, T., et al. (2022) · Journal of Arrhythmia · doi:10.1002/joa3.12714 · Cited by 49
The burden of proof: The current state of atrial fibrillation prevention and treatment trials
Zakeri, R., Wagoner, D. R. V., Calkins, H. G., Wong, T., Ross, H., Heist, E. K., Meyer, T. E., Kowey, P. R., Mentz, R. J., Cleland, J. G. F., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.01.032 · Cited by 44
Electrical management of heart failure: from pathophysiology to treatment
Prinzen, F. W., Auricchio, A., Müllens, W., Linde, C. M., & Huizar, J. F. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac088 · Cited by 48
“) arm irrespective of activity level.(54,55) Notably, only a small portion of patients included in these studies had HFrEF.”
Docherty, K. F., Shen, L., Castagno, D., Petrie, M. C., Abraham, W. T., Böhm, M., Desai, A. S., Dickstein, K., Køber, L. V., Packer, M., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1682 · Cited by 42
What are the costs of atrial fibrillation?
Blomstrom Lundqvist, C., Lip, G. Y. H., & Kirchhof, P. (2011) · Europace · doi:10.1093/europace/eur087 · Cited by 42
Atrial Fibrillation in the Elderly
Nantsupawat, T., NUGENT, K. M., & Phrommintikul, A. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0094-8 · Cited by 43
“embolism, bleeding, and life-threatening arrhythmias) [76].”
Gopinathannair, R., & Olshansky, B. (2015) · F1000Prime Reports · doi:10.12703/p7-60 · Cited by 52
Al‐Khatib, S. M. (2023) · Annals of Internal Medicine · doi:10.7326/aitc202307180 · Cited by 45
Alam, M., Bandeali, S. J., Shahzad, S. A., & Lakkis, N. M. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.8 · Cited by 43
Kim, H., Kim, T., Cha, M., Lee, J., Park, J., Park, J., Kang, K., Shim, J., Uhm, J., Kim, J., et al. (2017) · Korean Circulation Journal · doi:10.4070/kcj.2017.0146 · Cited by 43
Retrospective Evaluation of the Effect of Heart Rate on Survival in Dogs with Atrial Fibrillation
Pedro, B., Dukes‐McEwan, J., Oyama, M. A., Kraus, M. S., & Gelzer, A. R. (2017) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.14896 · Cited by 50
Tachycardia induced Cardiomyopathy
Kim, D. Y., Kim, S. H., & Ryu, K.-H. (2019) · Korean Circulation Journal · doi:10.4070/kcj.2019.0199 · Cited by 41
Nia, A. M., Gassanov, N., Dahlem, K. M., Caglayan, E., Hellmich, M., Erdmann, E., & Er, F. (2011) · Clinical Research in Cardiology · doi:10.1007/s00392-011-0319-y · Cited by 41
“Rate versus rhythm and tight versus lenient heart rate control have been reported to be equally weighted therapeutic options for patients with tachyarrhythmia [31–34].”
BackgroundSilverman, D. N., Rambod, M., Lustgarten, D. L., Lobel, R. M., LeWinter, M. M., & Meyer, M. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.017215 · Cited by 46
The physics of heart rhythm disorders
Rappel, W. (2022) · Physics Reports · doi:10.1016/j.physrep.2022.06.003 · Cited by 48
Optimal Blood Pressure in Patients With Atrial Fibrillation (from the AFFIRM Trial)
Badheka, A. O., Patel, N., Grover, P. M., Shah, N. N., Patel, N., Singh, V., Deshmukh, A. J., Mehta, K. D., Chothani, A., Savani, G. T., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.06.002 · Cited by 41
Kao, D. P., Davis, G. W., Aleong, R. G., O’Connor, C. M., Fiuzat, M., Carson, P. E., Anand, I. S., Plehn, J. F., Gottlieb, S. S., Silver, M. A., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs181 · Cited by 51
Symptoms In Atrial Fibrillation: A Contemporary Review And Future Directions.
Heidt, S. T., Kratz, A. L., Najarian, K., Hassett, A. L., Oral, H., Gonzalez, R., Nallamothu, B. K., Clauw, D. J., & Ghanbari, H. (2016) · PubMed Central · doi:10.4022/jafib.1422 · Cited by 57
Vermond, R. A., Crijns, H. J. G. M., Tijssen, J. G. P., ALINGS, A. M. W., van den Berg, M. P., Hillege, H. L., van Veldhuisen, D. J., Gelder, I. C. V., Rienstra, M., & for the RACE II investigators (2014) · EP Europace · doi:10.1093/europace/euu151 · Cited by 45
Self-citationCatheter Ablation for Atrial Fibrillation
Thomas, S. P., & Sanders, P. (2012) · Heart Lung and Circulation · doi:10.1016/j.hlc.2012.03.122 · Cited by 40
Metadata
- Authors
- Van Gelder, I. C., Groenveld, H. F., Crijns, H. J. G. M., Tuininga, Y. S., Tijssen, J. G. P., Alings, A. M., Hillege, H. L., Bergsma-Kadijk, J. A., Cornel, J. H., Kamp, O., Tukkie, R., Bosker, H. A., Van Veldhuisen, D. J., & Van den Berg, M. P.
- Affiliations
- University Medical Center Groningen (NL)
- Maastricht University Medical Centre (NL)
- Deventer Ziekenhuis (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- Medisch Centrum Alkmaar (NL)
- Rijnstate Hospital (NL)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-04-15
- Volume
- 362
- Issue
- 15
- Pages
- 1363-1373
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2102129403
- Cited by
- 1,033
- References
- 19
- Citations by year
- 2026: 36 · 2025: 55 · 2024: 59 · 2023: 61 · 2022: 56 · 2021: 63 · 2020: 44 · 2019: 50 · 2018: 45 · 2017: 62 · 2016: 56 · 2015: 51 · 2014: 81 · 2013: 94 · 2012: 83
- FWCI
- 68.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- atrial fibrillation, rate control, resting heart rate, non-inferiority, cardiovascular morbidity and mortality, heart failure hospitalization, stroke, hemorrhage, arrhythmic events, anticoagulation
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Anti-Arrhythmia Agents, Atrial Fibrillation, Calcium Channel Blockers, Female, Follow-Up Studies, Heart Rate, Humans, Male, Middle Aged, Confidence Intervals, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.